Our data further demonstrate that acetazolamide-induced tumor growth inhibition is associated with reduced cancer cell proliferation in hypoxic zones (Figure 6A and 6B), which is in accordance with what we observe following selective knockdown of CAIX (Figure 7D). The gene discussed is CA9; the disease is cancer.